Literature DB >> 2348387

The effects of corticotrophin-releasing factor and two antagonists on breathing movements in fetal sheep.

L Bennet1, B M Johnston, W W Vale, P D Gluckman.   

Abstract

1. The respiratory effects of corticotrophin-releasing factor (CRF) and the CRF antagonists alpha-helical CRF 9-41 (alpha hCRF) and [DPhe 12, Nle 21-38] rCRF (12-41) (DPhe CRF) have been studied in unanaesthetized fetal lambs of 125-140 days gestation. 2. CRF when given as a 10 micrograms bolus followed by a 5 micrograms h-1 infusion into a lateral cerebral ventricle caused prolonged continuous fetal breathing movements which were stimulated in both amplitude and frequency but which did not persist during hypoxia. 3. Lower doses of CRF (20 ng bolus followed by 10 ng h-1) increased the amplitude but not the frequency of fetal breathing movements which did not become continuous. 4. At higher doses (20 micrograms bolus followed by 10-15 micrograms h-1) CRF induced cerebral convulsions which were also associated with fetal breathing movements of increased amplitude and frequency. 5. The CRF antagonists alpha hCRF and DPhe CRF both inhibited fetal breathing movements and induced a prolonged apnoea which was resistant to the stimulatory effects of 5-6% hypercapnia. 6. We conclude that CRF stimulates breathing movements in the fetal lamb. The finding that administration of the CRF antagonists alone cause apnoea suggests that CRF may have a tonic role in the regulation of fetal breathing movements.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2348387      PMCID: PMC1190070          DOI: 10.1113/jphysiol.1990.sp017930

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  22 in total

1.  Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin.

Authors:  W Vale; J Spiess; C Rivier; J Rivier
Journal:  Science       Date:  1981-09-18       Impact factor: 47.728

2.  Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol.

Authors:  D N Orth; R V Jackson; G S DeCherney; C R DeBold; A N Alexander; D P Island; J Rivier; C Rivier; J Spiess; W Vale
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

3.  Synthetic competitive antagonists of corticotropin-releasing factor: effect on ACTH secretion in the rat.

Authors:  J Rivier; C Rivier; W Vale
Journal:  Science       Date:  1984-05-25       Impact factor: 47.728

4.  Corticotropin releasing factor produces behavioural activation in rats.

Authors:  R E Sutton; G F Koob; M Le Moal; J Rivier; W Vale
Journal:  Nature       Date:  1982-05-27       Impact factor: 49.962

5.  The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures.

Authors:  M E Gilbert
Journal:  Brain Res       Date:  1988-10-25       Impact factor: 3.252

6.  Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty.

Authors:  D R Britton; G F Koob; J Rivier; W Vale
Journal:  Life Sci       Date:  1982-07-26       Impact factor: 5.037

7.  Corticotropin releasing factor produces increases in brain excitability and convulsive seizures in rats.

Authors:  C L Ehlers; S J Henriksen; M Wang; J Rivier; W Vale; F E Bloom
Journal:  Brain Res       Date:  1983-11-14       Impact factor: 3.252

8.  Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study.

Authors:  L W Swanson; P E Sawchenko; J Rivier; W W Vale
Journal:  Neuroendocrinology       Date:  1983       Impact factor: 4.914

9.  GABA-mediated inhibition of breathing in the late gestation sheep fetus.

Authors:  B M Johnston; P D Gluckman
Journal:  J Dev Physiol       Date:  1983-12

10.  Respiratory movements and rapid eye movement sleep in the foetal lamb.

Authors:  G S Dawes; H E Fox; B M Leduc; G C Liggins; R T Richards
Journal:  J Physiol       Date:  1972-01       Impact factor: 5.182

View more
  6 in total

Review 1.  Safety and side effects of human and ovine corticotropin-releasing hormone administration in man.

Authors:  M Nink; U Krause; H Lehnert; J Beyer
Journal:  Klin Wochenschr       Date:  1991-03-18

Review 2.  Physiological and neurochemical aspects of corticotropin-releasing factor actions in the brain: the role of the locus coeruleus.

Authors:  H Lehnert; C Schulz; K Dieterich
Journal:  Neurochem Res       Date:  1998-08       Impact factor: 3.996

3.  Insulin-like growth factor-1 is a potent neuronal rescue agent after hypoxic-ischemic injury in fetal lambs.

Authors:  B M Johnston; E C Mallard; C E Williams; P D Gluckman
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

4.  Structural and molecular regulation of lung maturation by intratracheal vascular endothelial growth factor administration in the normally grown and placentally restricted fetus.

Authors:  Erin V McGillick; Sandra Orgeig; Janna L Morrison
Journal:  J Physiol       Date:  2015-12-23       Impact factor: 5.182

5.  Math1 is essential for the development of hindbrain neurons critical for perinatal breathing.

Authors:  Matthew F Rose; Jun Ren; Kaashif A Ahmad; Hsiao-Tuan Chao; Tiemo J Klisch; Adriano Flora; John J Greer; Huda Y Zoghbi
Journal:  Neuron       Date:  2009-11-12       Impact factor: 17.173

6.  Brain neuropeptides in central ventilatory and cardiovascular regulation in trout.

Authors:  Jean-Claude Le Mével; Frédéric Lancien; Nagi Mimassi; J Michael Conlon
Journal:  Front Endocrinol (Lausanne)       Date:  2012-10-30       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.